News
On our way to IVDR Compliance
We are very happy to announce that TÜV SÜD has verified the update of our quality management system to the latest revision – ISO13485:2016! This
Sweden’s best biotech workplace
Devyser is extremely proud to have been recognised as one of Sweden’s best workplaces (Small Organisations). Across all categories Devyser was the only nominated workplace
Simplify Gene Transcript Selection Using MANE Transcripts
For many genes, choosing the most optimal transcript for a specific analysis is a complex task. This is due to two main factors. Firstly, the
Genetic Data Sharing – Benefits and Burdens
Questions around genetic data sharing are coming into focus as our ability to sequence DNA improves, and digital privacy issues gain more awareness. Earlier this
Clinical trials highlights the importance of correct CFTR mutation detection in cystic fibrosis patients
Cystic Fibrosis is one of the most common genetic disorders. The disease is caused by mutations within the cystic fibrosis transmembrane conductance regulator gene (CFTR)
No Significant Reduction in Miscarriage Rates from NIPT Pre-Screening for Trisomy 21 as compared to invasive testing
A recent paper published by Malan et al in the Journal of the American Medical Association (JAMA) describes a clinical study conducted over two years
Visit Us at ASHG 2018!
Devyser is excited to be attending this years ASHG event in San Diego, next week. As one of the major events in the American continent
CRISPR Helps BRCA1 Researchers Determine Functional And Non-Functional Mutations
BRCA1 variants may generally be divided into three categories: benign variants, which cause no clinical concern; deleterious variants, which are associated with high risk of
Familial Hypercholesterolemia Awareness Day 2018
Familial Hypercholesterolemia (FH) is an hereditary disease which, despite being treatable, is vastly underdiagnosed. Individuals with FH have a reduced ability to remove LDL-cholesterol from